

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.18258259 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.18258259 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.99084046 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.99084046 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.61883554 |
| 6 | glyoxylate metabolic process (GO:0046487) | 6.60520820 |
| 7 | androgen biosynthetic process (GO:0006702) | 6.51363330 |
| 8 | glucocorticoid biosynthetic process (GO:0006704) | 6.44529291 |
| 9 | lysine metabolic process (GO:0006553) | 6.40793422 |
| 10 | lysine catabolic process (GO:0006554) | 6.40793422 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.12648558 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.12648558 |
| 13 | tryptophan catabolic process (GO:0006569) | 6.12648558 |
| 14 | cysteine metabolic process (GO:0006534) | 6.05272516 |
| 15 | urate metabolic process (GO:0046415) | 5.93978938 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.77982474 |
| 17 | kynurenine metabolic process (GO:0070189) | 5.76211455 |
| 18 | * drug transmembrane transport (GO:0006855) | 5.42417074 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.38286000 |
| 20 | serine family amino acid catabolic process (GO:0009071) | 5.34872621 |
| 21 | drug catabolic process (GO:0042737) | 5.30259540 |
| 22 | bile acid biosynthetic process (GO:0006699) | 5.25063632 |
| 23 | homocysteine metabolic process (GO:0050667) | 5.21460056 |
| 24 | amino-acid betaine metabolic process (GO:0006577) | 5.06899724 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.05436206 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 4.88832206 |
| 27 | glucocorticoid metabolic process (GO:0008211) | 4.88377193 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.85352080 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 4.83079445 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 4.83060942 |
| 31 | exogenous drug catabolic process (GO:0042738) | 4.78660091 |
| 32 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 4.76791781 |
| 33 | short-chain fatty acid metabolic process (GO:0046459) | 4.76534403 |
| 34 | alpha-amino acid catabolic process (GO:1901606) | 4.71180579 |
| 35 | estrogen biosynthetic process (GO:0006703) | 4.70002186 |
| 36 | regulation of gonadotropin secretion (GO:0032276) | 4.69548775 |
| 37 | urea cycle (GO:0000050) | 4.67936036 |
| 38 | urea metabolic process (GO:0019627) | 4.67936036 |
| 39 | aspartate family amino acid catabolic process (GO:0009068) | 4.63258307 |
| 40 | epoxygenase P450 pathway (GO:0019373) | 4.61401696 |
| 41 | serine family amino acid metabolic process (GO:0009069) | 4.56909101 |
| 42 | * drug transport (GO:0015893) | 4.56318269 |
| 43 | cellular modified amino acid catabolic process (GO:0042219) | 4.55699824 |
| 44 | glutamate metabolic process (GO:0006536) | 4.47245010 |
| 45 | cellular amino acid catabolic process (GO:0009063) | 4.46769984 |
| 46 | cholesterol efflux (GO:0033344) | 4.42552458 |
| 47 | bile acid metabolic process (GO:0008206) | 4.41221139 |
| 48 | 2-oxoglutarate metabolic process (GO:0006103) | 4.38975938 |
| 49 | nitrogen cycle metabolic process (GO:0071941) | 4.35466177 |
| 50 | androgen metabolic process (GO:0008209) | 4.33826573 |
| 51 | indolalkylamine metabolic process (GO:0006586) | 4.31839936 |
| 52 | cellular glucuronidation (GO:0052695) | 4.31343812 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 4.30348269 |
| 54 | benzene-containing compound metabolic process (GO:0042537) | 4.27936343 |
| 55 | tyrosine metabolic process (GO:0006570) | 4.25639785 |
| 56 | acetyl-CoA metabolic process (GO:0006084) | 4.25426880 |
| 57 | omega-hydroxylase P450 pathway (GO:0097267) | 4.22101777 |
| 58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.21733636 |
| 59 | protein carboxylation (GO:0018214) | 4.21733636 |
| 60 | fatty acid beta-oxidation (GO:0006635) | 4.19849294 |
| 61 | negative regulation of fibrinolysis (GO:0051918) | 4.17979257 |
| 62 | ketone body metabolic process (GO:1902224) | 4.17069488 |
| 63 | response to mercury ion (GO:0046689) | 4.16827329 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 4.16379369 |
| 65 | amine catabolic process (GO:0009310) | 4.16379369 |
| 66 | high-density lipoprotein particle remodeling (GO:0034375) | 4.14080687 |
| 67 | serine family amino acid biosynthetic process (GO:0009070) | 4.14051170 |
| 68 | carnitine metabolic process (GO:0009437) | 4.08172031 |
| 69 | cellular response to gonadotropin stimulus (GO:0071371) | 4.06406192 |
| 70 | fatty acid oxidation (GO:0019395) | 4.06125224 |
| 71 | glycine metabolic process (GO:0006544) | 4.02827835 |
| 72 | organic acid catabolic process (GO:0016054) | 4.02548973 |
| 73 | carboxylic acid catabolic process (GO:0046395) | 4.02548973 |
| 74 | uronic acid metabolic process (GO:0006063) | 4.02408818 |
| 75 | glucuronate metabolic process (GO:0019585) | 4.02408818 |
| 76 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00605942 |
| 77 | valine metabolic process (GO:0006573) | 3.99072835 |
| 78 | ethanol oxidation (GO:0006069) | 3.98938223 |
| 79 | lipid oxidation (GO:0034440) | 3.98263220 |
| 80 | regulation of fibrinolysis (GO:0051917) | 3.98046317 |
| 81 | coenzyme catabolic process (GO:0009109) | 3.95776995 |
| 82 | negative regulation of sterol transport (GO:0032372) | 3.95169945 |
| 83 | negative regulation of cholesterol transport (GO:0032375) | 3.95169945 |
| 84 | phosphate ion transport (GO:0006817) | 3.94416423 |
| 85 | complement activation, alternative pathway (GO:0006957) | 3.91994425 |
| 86 | regulation of protein activation cascade (GO:2000257) | 3.90148181 |
| 87 | blood coagulation, intrinsic pathway (GO:0007597) | 3.89251862 |
| 88 | oxidative demethylation (GO:0070989) | 3.89161502 |
| 89 | monocarboxylic acid catabolic process (GO:0072329) | 3.88948540 |
| 90 | intestinal cholesterol absorption (GO:0030299) | 3.87143377 |
| 91 | regulation of triglyceride catabolic process (GO:0010896) | 3.87095959 |
| 92 | aldehyde catabolic process (GO:0046185) | 3.86085533 |
| 93 | fatty acid catabolic process (GO:0009062) | 3.83974033 |
| 94 | branched-chain amino acid metabolic process (GO:0009081) | 3.83811566 |
| 95 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.82805008 |
| 96 | response to follicle-stimulating hormone (GO:0032354) | 3.80457821 |
| 97 | triglyceride homeostasis (GO:0070328) | 3.77431913 |
| 98 | acylglycerol homeostasis (GO:0055090) | 3.77431913 |
| 99 | phosphate ion transmembrane transport (GO:0035435) | 3.76030742 |
| 100 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.75550130 |
| 101 | drug metabolic process (GO:0017144) | 3.74402089 |
| 102 | quaternary ammonium group transport (GO:0015697) | 3.73610376 |
| 103 | flavonoid metabolic process (GO:0009812) | 3.72177228 |
| 104 | branched-chain amino acid catabolic process (GO:0009083) | 3.71424665 |
| 105 | regulation of cholesterol homeostasis (GO:2000188) | 3.70239397 |
| 106 | tricarboxylic acid metabolic process (GO:0072350) | 3.69840196 |
| 107 | regulation of cholesterol esterification (GO:0010872) | 3.69015341 |
| 108 | regulation of complement activation (GO:0030449) | 3.63580402 |
| 109 | regulation of plasminogen activation (GO:0010755) | 3.63421638 |
| 110 | regulation of bile acid biosynthetic process (GO:0070857) | 3.62821540 |
| 111 | bile acid and bile salt transport (GO:0015721) | 3.60469611 |
| 112 | reverse cholesterol transport (GO:0043691) | 3.58552796 |
| 113 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.58509544 |
| 114 | hormone biosynthetic process (GO:0042446) | 3.58477721 |
| 115 | plasma lipoprotein particle remodeling (GO:0034369) | 3.56822406 |
| 116 | protein-lipid complex remodeling (GO:0034368) | 3.56822406 |
| 117 | macromolecular complex remodeling (GO:0034367) | 3.56822406 |
| 118 | sodium-independent organic anion transport (GO:0043252) | 3.56440013 |
| 119 | low-density lipoprotein particle clearance (GO:0034383) | 3.53556440 |
| 120 | arginine metabolic process (GO:0006525) | 3.52779540 |
| 121 | S-adenosylmethionine metabolic process (GO:0046500) | 3.48586392 |
| 122 | small molecule catabolic process (GO:0044282) | 3.41934428 |
| 123 | plasma lipoprotein particle organization (GO:0071827) | 3.40029585 |
| 124 | response to nitrosative stress (GO:0051409) | 3.39870476 |
| 125 | regulation of triglyceride metabolic process (GO:0090207) | 3.38956460 |
| 126 | imidazole-containing compound metabolic process (GO:0052803) | 3.38829531 |
| 127 | fibrinolysis (GO:0042730) | 3.37944412 |
| 128 | positive regulation of male gonad development (GO:2000020) | 3.37541212 |
| 129 | cholesterol catabolic process (GO:0006707) | 3.30477686 |
| 130 | sterol catabolic process (GO:0016127) | 3.30477686 |
| 131 | cholesterol transport (GO:0030301) | 3.21403606 |
| 132 | sterol transport (GO:0015918) | 3.21403606 |
| 133 | steroid catabolic process (GO:0006706) | 3.21102614 |
| 134 | negative regulation of protein activation cascade (GO:2000258) | 3.21001345 |
| 135 | amyloid precursor protein catabolic process (GO:0042987) | 3.17740469 |
| 136 | protein-lipid complex subunit organization (GO:0071825) | 3.16020306 |
| 137 | heme transport (GO:0015886) | 3.06446803 |
| 138 | phospholipid efflux (GO:0033700) | 3.06417607 |
| 139 | positive regulation of lipid storage (GO:0010884) | 3.06096488 |
| 140 | estrogen metabolic process (GO:0008210) | 3.03427913 |
| 141 | low-density lipoprotein particle remodeling (GO:0034374) | 2.99496545 |
| 142 | protein activation cascade (GO:0072376) | 2.98965389 |
| 143 | negative regulation of lipase activity (GO:0060192) | 2.97400966 |
| 144 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.96334140 |
| 145 | response to leptin (GO:0044321) | 2.91814187 |
| 146 | steroid biosynthetic process (GO:0006694) | 2.90809096 |
| 147 | negative regulation of hemostasis (GO:1900047) | 2.89714088 |
| 148 | negative regulation of blood coagulation (GO:0030195) | 2.89714088 |
| 149 | cholesterol homeostasis (GO:0042632) | 2.89316409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.95505995 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.81668814 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.14783217 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.84358689 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.28760179 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.71411863 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.15561405 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.87039091 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.43630450 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.84091141 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.63021090 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.48019499 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.44674842 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.38031094 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.30031408 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.14026001 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.0340629 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90520425 |
| 19 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.90169969 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86313663 |
| 21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.85260680 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79309826 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.78848054 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.77776831 |
| 25 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64864504 |
| 26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.55823702 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.53414279 |
| 28 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.51457307 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.48771520 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48396134 |
| 31 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.43634456 |
| 32 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.43347279 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.41681326 |
| 34 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.36421439 |
| 35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.34986411 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34761027 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.32903849 |
| 38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.30910451 |
| 39 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29559247 |
| 40 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29031285 |
| 41 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.28291997 |
| 42 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.28291997 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.28069834 |
| 44 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27781413 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.25830799 |
| 46 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.25012565 |
| 47 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24298899 |
| 48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.23849365 |
| 49 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.23583589 |
| 50 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.23295035 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23135135 |
| 52 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23037231 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20387331 |
| 54 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19429578 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18193640 |
| 56 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17014138 |
| 57 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.16898526 |
| 58 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15234619 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15088381 |
| 60 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14969396 |
| 61 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14889332 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.13843449 |
| 63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12493616 |
| 64 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12117160 |
| 65 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10720152 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09535900 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.09180690 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08863974 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07999980 |
| 70 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.06309485 |
| 71 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06270976 |
| 72 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05705334 |
| 73 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04477105 |
| 74 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04081243 |
| 75 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03562889 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03457171 |
| 77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03284805 |
| 78 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02770031 |
| 79 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.02270738 |
| 80 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02021219 |
| 81 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01625733 |
| 82 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01334893 |
| 83 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01334893 |
| 84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00930726 |
| 85 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.99896713 |
| 86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98886928 |
| 87 | NCOR_22424771_ChIP-Seq_293T_Human | 0.98621350 |
| 88 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96843133 |
| 89 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96582658 |
| 90 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96582658 |
| 91 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95480736 |
| 92 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91517449 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91464017 |
| 94 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.91173186 |
| 95 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.89892680 |
| 96 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.89570041 |
| 97 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.89294670 |
| 98 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.88864208 |
| 99 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87837791 |
| 100 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.86594191 |
| 101 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86534472 |
| 102 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86258478 |
| 103 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.85303909 |
| 104 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.85182478 |
| 105 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82914695 |
| 106 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80734918 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80331802 |
| 108 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.79712769 |
| 109 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79115036 |
| 110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78499842 |
| 111 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77415295 |
| 112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.75074128 |
| 113 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.73638919 |
| 114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.73638919 |
| 115 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.73335013 |
| 116 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71031493 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70187592 |
| 118 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.69993520 |
| 119 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.69993520 |
| 120 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69784911 |
| 121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69629535 |
| 122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.68965944 |
| 123 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.68341439 |
| 124 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.67072035 |
| 125 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.66767283 |
| 126 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66284556 |
| 127 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.66052123 |
| 128 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.64940030 |
| 129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.63893903 |
| 130 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.63754197 |
| 131 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.63627175 |
| 132 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62902915 |
| 133 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.62310976 |
| 134 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61696819 |
| 135 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59150521 |
| 136 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.56502377 |
| 137 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.55382703 |
| 138 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55328028 |
| 139 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.55080325 |
| 140 | CBP_21632823_ChIP-Seq_H3396_Human | 0.54925968 |
| 141 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54733379 |
| 142 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.54695145 |
| 143 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.53612209 |
| 144 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.52953049 |
| 145 | GATA2_19941826_ChIP-Seq_K562_Human | 0.51746505 |
| 146 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51338494 |
| 147 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.50970009 |
| 148 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50705146 |
| 149 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50292313 |
| 150 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.49838128 |
| 151 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.49820591 |
| 152 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.49479017 |
| 153 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.49358416 |
| 154 | GATA1_19941826_ChIP-Seq_K562_Human | 0.49340877 |
| 155 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.48864758 |
| 156 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.48641908 |
| 157 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48475616 |
| 158 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.47653322 |
| 159 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47391911 |
| 160 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.47051639 |
| 161 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.47048924 |
| 162 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.46934658 |
| 163 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.46362831 |
| 164 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.46339960 |
| 165 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46036406 |
| 166 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.45418014 |
| 167 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.45376020 |
| 168 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.44987946 |
| 169 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.44447440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.24965188 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.72066088 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.58892077 |
| 4 | MP0005365_abnormal_bile_salt | 5.41682851 |
| 5 | * MP0008875_abnormal_xenobiotic_pharmacok | 4.54522817 |
| 6 | MP0003252_abnormal_bile_duct | 3.78665883 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.74469680 |
| 8 | MP0003283_abnormal_digestive_organ | 3.70064288 |
| 9 | * MP0005332_abnormal_amino_acid | 3.63047742 |
| 10 | MP0003195_calcinosis | 3.59182713 |
| 11 | MP0004019_abnormal_vitamin_homeostasis | 3.24806153 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.91805684 |
| 13 | MP0008004_abnormal_stomach_pH | 2.83477687 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.74625877 |
| 15 | MP0009840_abnormal_foam_cell | 2.44581347 |
| 16 | MP0005083_abnormal_biliary_tract | 2.40659752 |
| 17 | MP0004043_abnormal_pH_regulation | 2.36335644 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.29299684 |
| 19 | MP0009643_abnormal_urine_homeostasis | 2.24564471 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.96469405 |
| 21 | MP0004145_abnormal_muscle_electrophysio | 1.90130879 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.89076848 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.88231324 |
| 24 | MP0008995_early_reproductive_senescence | 1.83998125 |
| 25 | MP0000609_abnormal_liver_physiology | 1.81732751 |
| 26 | MP0000639_abnormal_adrenal_gland | 1.74421647 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.71765267 |
| 28 | MP0005636_abnormal_mineral_homeostasis | 1.70967792 |
| 29 | MP0004233_abnormal_muscle_weight | 1.61933726 |
| 30 | MP0005451_abnormal_body_composition | 1.59774672 |
| 31 | MP0001764_abnormal_homeostasis | 1.55864384 |
| 32 | MP0003186_abnormal_redox_activity | 1.55144748 |
| 33 | MP0001756_abnormal_urination | 1.47860562 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.37087185 |
| 35 | MP0001765_abnormal_ion_homeostasis | 1.36716396 |
| 36 | MP0005551_abnormal_eye_electrophysiolog | 1.36463353 |
| 37 | MP0002136_abnormal_kidney_physiology | 1.30532764 |
| 38 | MP0003868_abnormal_feces_composition | 1.25609629 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 1.21781910 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.06977414 |
| 41 | MP0005670_abnormal_white_adipose | 1.04751014 |
| 42 | MP0003879_abnormal_hair_cell | 1.03440834 |
| 43 | MP0000598_abnormal_liver_morphology | 1.03259583 |
| 44 | MP0002160_abnormal_reproductive_system | 0.99909962 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 0.98993732 |
| 46 | MP0001501_abnormal_sleep_pattern | 0.98713530 |
| 47 | MP0009764_decreased_sensitivity_to | 0.98239276 |
| 48 | MP0005646_abnormal_pituitary_gland | 0.96823810 |
| 49 | MP0005410_abnormal_fertilization | 0.96807555 |
| 50 | MP0008775_abnormal_heart_ventricle | 0.96061932 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 0.93161426 |
| 52 | MP0002332_abnormal_exercise_endurance | 0.93131436 |
| 53 | MP0002876_abnormal_thyroid_physiology | 0.92431995 |
| 54 | MP0003122_maternal_imprinting | 0.92159660 |
| 55 | MP0005389_reproductive_system_phenotype | 0.89149513 |
| 56 | * MP0009642_abnormal_blood_homeostasis | 0.88423139 |
| 57 | MP0005187_abnormal_penis_morphology | 0.86280092 |
| 58 | MP0003315_abnormal_perineum_morphology | 0.85521499 |
| 59 | MP0009697_abnormal_copulation | 0.85275782 |
| 60 | MP0005535_abnormal_body_temperature | 0.84789963 |
| 61 | MP0001324_abnormal_eye_pigmentation | 0.83469847 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 0.81599766 |
| 63 | MP0005647_abnormal_sex_gland | 0.81182737 |
| 64 | MP0008469_abnormal_protein_level | 0.78941198 |
| 65 | MP0002078_abnormal_glucose_homeostasis | 0.78374092 |
| 66 | MP0004130_abnormal_muscle_cell | 0.78262621 |
| 67 | MP0003011_delayed_dark_adaptation | 0.75969200 |
| 68 | MP0009763_increased_sensitivity_to | 0.75803433 |
| 69 | MP0000604_amyloidosis | 0.75568725 |
| 70 | MP0005058_abnormal_lysosome_morphology | 0.74945699 |
| 71 | MP0002928_abnormal_bile_duct | 0.73752310 |
| 72 | MP0010368_abnormal_lymphatic_system | 0.71456148 |
| 73 | MP0005666_abnormal_adipose_tissue | 0.71376975 |
| 74 | MP0005220_abnormal_exocrine_pancreas | 0.71375530 |
| 75 | MP0001919_abnormal_reproductive_system | 0.71304088 |
| 76 | MP0001661_extended_life_span | 0.71023616 |
| 77 | MP0000230_abnormal_systemic_arterial | 0.70554134 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 0.70442270 |
| 79 | MP0003632_abnormal_nervous_system | 0.70268007 |
| 80 | MP0005376_homeostasis/metabolism_phenot | 0.69430758 |
| 81 | MP0005408_hypopigmentation | 0.69154028 |
| 82 | MP0004215_abnormal_myocardial_fiber | 0.68756638 |
| 83 | MP0002254_reproductive_system_inflammat | 0.68355116 |
| 84 | MP0000013_abnormal_adipose_tissue | 0.67865911 |
| 85 | MP0003718_maternal_effect | 0.66153323 |
| 86 | MP0000538_abnormal_urinary_bladder | 0.65933880 |
| 87 | MP0002971_abnormal_brown_adipose | 0.65666480 |
| 88 | MP0002736_abnormal_nociception_after | 0.65505292 |
| 89 | MP0002168_other_aberrant_phenotype | 0.65390329 |
| 90 | MP0008961_abnormal_basal_metabolism | 0.65236530 |
| 91 | MP0001968_abnormal_touch/_nociception | 0.64583143 |
| 92 | MP0005266_abnormal_metabolism | 0.64473171 |
| 93 | MP0003878_abnormal_ear_physiology | 0.63542533 |
| 94 | MP0005377_hearing/vestibular/ear_phenot | 0.63542533 |
| 95 | MP0003646_muscle_fatigue | 0.63426947 |
| 96 | MP0001485_abnormal_pinna_reflex | 0.63235021 |
| 97 | MP0004924_abnormal_behavior | 0.63206552 |
| 98 | MP0005386_behavior/neurological_phenoty | 0.63206552 |
| 99 | MP0002090_abnormal_vision | 0.62787194 |
| 100 | MP0010386_abnormal_urinary_bladder | 0.61114041 |
| 101 | MP0005253_abnormal_eye_physiology | 0.60403030 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.58721044 |
| 103 | MP0003698_abnormal_male_reproductive | 0.58665880 |
| 104 | MP0003638_abnormal_response/metabolism_ | 0.58377578 |
| 105 | MP0009745_abnormal_behavioral_response | 0.56997410 |
| 106 | MP0003699_abnormal_female_reproductive | 0.56838860 |
| 107 | MP0005395_other_phenotype | 0.55986592 |
| 108 | MP0001984_abnormal_olfaction | 0.55409107 |
| 109 | MP0005334_abnormal_fat_pad | 0.54745573 |
| 110 | MP0002127_abnormal_cardiovascular_syste | 0.54395609 |
| 111 | MP0005330_cardiomyopathy | 0.53920498 |
| 112 | MP0000653_abnormal_sex_gland | 0.53483329 |
| 113 | MP0003329_amyloid_beta_deposits | 0.52610818 |
| 114 | MP0001119_abnormal_female_reproductive | 0.52544884 |
| 115 | MP0003690_abnormal_glial_cell | 0.52342100 |
| 116 | MP0000631_abnormal_neuroendocrine_gland | 0.51434264 |
| 117 | MP0001958_emphysema | 0.51360762 |
| 118 | MP0001929_abnormal_gametogenesis | 0.50129959 |
| 119 | MP0002135_abnormal_kidney_morphology | 0.49760023 |
| 120 | MP0003300_gastrointestinal_ulcer | 0.48992501 |
| 121 | MP0004147_increased_porphyrin_level | 0.47568245 |
| 122 | MP0009053_abnormal_anal_canal | 0.47234674 |
| 123 | MP0003953_abnormal_hormone_level | 0.45794964 |
| 124 | MP0002796_impaired_skin_barrier | 0.41739535 |
| 125 | MP0004264_abnormal_extraembryonic_tissu | 0.41308997 |
| 126 | MP0002269_muscular_atrophy | 0.39683493 |
| 127 | MP0009672_abnormal_birth_weight | 0.38803176 |
| 128 | MP0008874_decreased_physiological_sensi | 0.36240996 |
| 129 | MP0005166_decreased_susceptibility_to | 0.34780473 |
| 130 | MP0005448_abnormal_energy_balance | 0.34307989 |
| 131 | MP0010234_abnormal_vibrissa_follicle | 0.33396268 |
| 132 | MP0003075_altered_response_to | 0.31925156 |
| 133 | MP0005165_increased_susceptibility_to | 0.30830817 |
| 134 | MP0008872_abnormal_physiological_respon | 0.30598046 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.30490240 |
| 136 | MP0000747_muscle_weakness | 0.30118860 |
| 137 | MP0003724_increased_susceptibility_to | 0.29876132 |
| 138 | MP0008873_increased_physiological_sensi | 0.29074849 |
| 139 | MP0002896_abnormal_bone_mineralization | 0.28520358 |
| 140 | MP0009384_cardiac_valve_regurgitation | 0.27276491 |
| 141 | MP0004036_abnormal_muscle_relaxation | 0.27043268 |
| 142 | MP0004782_abnormal_surfactant_physiolog | 0.26531346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.04146109 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.53085259 |
| 3 | Hyperglycinuria (HP:0003108) | 5.18507867 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.10709013 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.07947943 |
| 6 | Xanthomatosis (HP:0000991) | 5.06699652 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.04351539 |
| 8 | Gout (HP:0001997) | 5.00058455 |
| 9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.74435282 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 4.74435282 |
| 11 | Ketosis (HP:0001946) | 4.73415639 |
| 12 | Hyperammonemia (HP:0001987) | 4.52934546 |
| 13 | Hyperglycinemia (HP:0002154) | 4.44886904 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 4.27999920 |
| 15 | Prolonged partial thromboplastin time (HP:0003645) | 4.22130445 |
| 16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.21896192 |
| 17 | Ketoacidosis (HP:0001993) | 4.18030242 |
| 18 | Proximal tubulopathy (HP:0000114) | 4.01773362 |
| 19 | Abnormality of purine metabolism (HP:0004352) | 4.01115500 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.95733465 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.91004744 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 3.85638883 |
| 23 | Gonadal dysgenesis (HP:0000133) | 3.80877907 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.74787034 |
| 25 | Abnormality of nucleobase metabolism (HP:0010932) | 3.69468782 |
| 26 | Generalized aminoaciduria (HP:0002909) | 3.62470617 |
| 27 | Hyperuricemia (HP:0002149) | 3.59083805 |
| 28 | Increased purine levels (HP:0004368) | 3.59083805 |
| 29 | Glomerulonephritis (HP:0000099) | 3.52640821 |
| 30 | Hypokalemic alkalosis (HP:0001949) | 3.46581871 |
| 31 | Gonadotropin excess (HP:0000837) | 3.46243315 |
| 32 | Increased circulating renin level (HP:0000848) | 3.46061559 |
| 33 | Delayed CNS myelination (HP:0002188) | 3.44698433 |
| 34 | Alkalosis (HP:0001948) | 3.43556126 |
| 35 | Joint hemorrhage (HP:0005261) | 3.40586990 |
| 36 | Osteomalacia (HP:0002749) | 3.39345245 |
| 37 | Complement deficiency (HP:0004431) | 3.32964019 |
| 38 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.31874743 |
| 39 | Hypolipoproteinemia (HP:0010981) | 3.29949730 |
| 40 | Epidermoid cyst (HP:0200040) | 3.27671625 |
| 41 | Short tibia (HP:0005736) | 3.24409179 |
| 42 | Male pseudohermaphroditism (HP:0000037) | 3.24328204 |
| 43 | Hyperactive renin-angiotensin system (HP:0000841) | 3.20787463 |
| 44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.20111852 |
| 45 | Dicarboxylic aciduria (HP:0003215) | 3.20111852 |
| 46 | Metabolic acidosis (HP:0001942) | 3.17368771 |
| 47 | Abnormality of methionine metabolism (HP:0010901) | 3.16241550 |
| 48 | Relative macrocephaly (HP:0004482) | 3.14698471 |
| 49 | Vascular calcification (HP:0004934) | 3.13050965 |
| 50 | Fat malabsorption (HP:0002630) | 3.11515667 |
| 51 | Metabolic alkalosis (HP:0200114) | 3.11303080 |
| 52 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.06175347 |
| 53 | Abnormality of serum amino acid levels (HP:0003112) | 3.02773582 |
| 54 | Abnormality of urine glucose concentration (HP:0011016) | 3.00917917 |
| 55 | Glycosuria (HP:0003076) | 3.00917917 |
| 56 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.00298474 |
| 57 | Abnormal urine output (HP:0012590) | 2.98465168 |
| 58 | Hypoalphalipoproteinemia (HP:0003233) | 2.97961330 |
| 59 | Abnormality of the common coagulation pathway (HP:0010990) | 2.97336712 |
| 60 | Polyuria (HP:0000103) | 2.93131240 |
| 61 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.93126866 |
| 62 | Lethargy (HP:0001254) | 2.93018661 |
| 63 | Abnormality of carpal bone ossification (HP:0006257) | 2.84571445 |
| 64 | Hypomagnesemia (HP:0002917) | 2.81923540 |
| 65 | Hypoplasia of the uterus (HP:0000013) | 2.81820212 |
| 66 | Conjugated hyperbilirubinemia (HP:0002908) | 2.80531746 |
| 67 | Cardiovascular calcification (HP:0011915) | 2.78195495 |
| 68 | Abnormality of proline metabolism (HP:0010907) | 2.77653878 |
| 69 | Hydroxyprolinuria (HP:0003080) | 2.77653878 |
| 70 | Cerebral palsy (HP:0100021) | 2.76525899 |
| 71 | Abnormality of renal excretion (HP:0011036) | 2.75970767 |
| 72 | Abnormality of chloride homeostasis (HP:0011422) | 2.75059354 |
| 73 | Hyperbilirubinemia (HP:0002904) | 2.74952634 |
| 74 | Hepatocellular carcinoma (HP:0001402) | 2.71409661 |
| 75 | Sex reversal (HP:0012245) | 2.71061608 |
| 76 | Abnormal sex determination (HP:0012244) | 2.71061608 |
| 77 | Vomiting (HP:0002013) | 2.65050416 |
| 78 | Malnutrition (HP:0004395) | 2.64514159 |
| 79 | Anomalous pulmonary venous return (HP:0010772) | 2.57925384 |
| 80 | Enlarged kidneys (HP:0000105) | 2.57083552 |
| 81 | Cerebral edema (HP:0002181) | 2.55924247 |
| 82 | Spontaneous abortion (HP:0005268) | 2.54355079 |
| 83 | Rickets (HP:0002748) | 2.54153019 |
| 84 | Hypercholesterolemia (HP:0003124) | 2.53318005 |
| 85 | Arthropathy (HP:0003040) | 2.51785231 |
| 86 | Abnormality of the intrinsic pathway (HP:0010989) | 2.48968145 |
| 87 | Nephritis (HP:0000123) | 2.45382068 |
| 88 | Decreased circulating renin level (HP:0003351) | 2.42614536 |
| 89 | Irritability (HP:0000737) | 2.38789799 |
| 90 | Cupped ear (HP:0000378) | 2.36458732 |
| 91 | Facial shape deformation (HP:0011334) | 2.35762791 |
| 92 | Potter facies (HP:0002009) | 2.35762791 |
| 93 | Spastic diplegia (HP:0001264) | 2.34382406 |
| 94 | Neonatal onset (HP:0003623) | 2.33930585 |
| 95 | Abnormality of magnesium homeostasis (HP:0004921) | 2.31878463 |
| 96 | Abnormality of complement system (HP:0005339) | 2.30951866 |
| 97 | Nephrolithiasis (HP:0000787) | 2.30624974 |
| 98 | Late onset (HP:0003584) | 2.27632987 |
| 99 | Renal tubular acidosis (HP:0001947) | 2.26799261 |
| 100 | Azoospermia (HP:0000027) | 2.26467365 |
| 101 | Hyperphosphaturia (HP:0003109) | 2.26293397 |
| 102 | Polydipsia (HP:0001959) | 2.23602078 |
| 103 | Abnormal drinking behavior (HP:0030082) | 2.23602078 |
| 104 | Fair hair (HP:0002286) | 2.22946662 |
| 105 | Steatorrhea (HP:0002570) | 2.22847194 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 2.21738760 |
| 107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.19974348 |
| 108 | Ovoid vertebral bodies (HP:0003300) | 2.18491022 |
| 109 | Abnormal hand bone ossification (HP:0010660) | 2.18347526 |
| 110 | Abnormal biliary tract physiology (HP:0012439) | 2.17369534 |
| 111 | Bile duct proliferation (HP:0001408) | 2.17369534 |
| 112 | Retinal atrophy (HP:0001105) | 2.16408082 |
| 113 | Reduced antithrombin III activity (HP:0001976) | 2.16304638 |
| 114 | Abnormality of alanine metabolism (HP:0010916) | 2.14924280 |
| 115 | Hyperalaninemia (HP:0003348) | 2.14924280 |
| 116 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.14924280 |
| 117 | Nausea (HP:0002018) | 2.12619556 |
| 118 | Confusion (HP:0001289) | 2.12212002 |
| 119 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09402217 |
| 120 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.08936882 |
| 121 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.07431278 |
| 122 | Hypoglycemic seizures (HP:0002173) | 2.06885182 |
| 123 | Absent phalangeal crease (HP:0006109) | 2.06854282 |
| 124 | Abnormality of the pulmonary veins (HP:0011718) | 2.05583394 |
| 125 | Pancreatitis (HP:0001733) | 2.05428426 |
| 126 | Myocardial infarction (HP:0001658) | 2.05411273 |
| 127 | Abnormality of renin-angiotensin system (HP:0000847) | 2.04074631 |
| 128 | Skin nodule (HP:0200036) | 2.03704668 |
| 129 | Abnormal urine phosphate concentration (HP:0012599) | 2.03190164 |
| 130 | Abnormality of the alveolar ridges (HP:0006477) | 2.03094336 |
| 131 | Partial agenesis of the corpus callosum (HP:0001338) | 2.02407368 |
| 132 | Hypokalemia (HP:0002900) | 2.01969252 |
| 133 | Hypophosphatemic rickets (HP:0004912) | 2.01571238 |
| 134 | Hyperaldosteronism (HP:0000859) | 2.00621376 |
| 135 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.99701848 |
| 136 | Hypophosphatemia (HP:0002148) | 1.99369671 |
| 137 | Renal salt wasting (HP:0000127) | 1.99043285 |
| 138 | Short femoral neck (HP:0100864) | 1.99031489 |
| 139 | Ureteral duplication (HP:0000073) | 1.97572595 |
| 140 | Systemic lupus erythematosus (HP:0002725) | 1.96689479 |
| 141 | Tetany (HP:0001281) | 1.94626104 |
| 142 | Mitral stenosis (HP:0001718) | 1.91953904 |
| 143 | Congenital sensorineural hearing impairment (HP:0008527) | 1.88209896 |
| 144 | Flared iliac wings (HP:0002869) | 1.86865042 |
| 145 | Type II lissencephaly (HP:0007260) | 1.85577290 |
| 146 | Abnormal ossification of hand bones (HP:0005921) | 1.85331365 |
| 147 | Abnormality of the renal cortex (HP:0011035) | 1.82194709 |
| 148 | Renal cortical cysts (HP:0000803) | 1.82030435 |
| 149 | Pancreatic cysts (HP:0001737) | 1.81134649 |
| 150 | Hyperventilation (HP:0002883) | 1.80090570 |
| 151 | Abolished electroretinogram (ERG) (HP:0000550) | 1.74623754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.50893027 |
| 2 | WNK4 | 5.44433912 |
| 3 | WNK3 | 4.89957352 |
| 4 | OXSR1 | 4.26724648 |
| 5 | FGFR4 | 3.23193315 |
| 6 | SIK1 | 2.82408820 |
| 7 | ADRBK2 | 2.79194133 |
| 8 | ERN1 | 2.62440507 |
| 9 | STK38L | 2.44257180 |
| 10 | INSRR | 2.38284323 |
| 11 | STK39 | 2.30524035 |
| 12 | BMPR1B | 2.23665810 |
| 13 | ACVR1B | 2.13955408 |
| 14 | MAP4K2 | 1.93095219 |
| 15 | PDK4 | 1.92979385 |
| 16 | PDK3 | 1.92979385 |
| 17 | MST1R | 1.92359824 |
| 18 | PRPF4B | 1.91461597 |
| 19 | TAOK2 | 1.89460970 |
| 20 | NEK1 | 1.77610564 |
| 21 | AKT3 | 1.75755646 |
| 22 | ERBB4 | 1.68745553 |
| 23 | PKN2 | 1.67867326 |
| 24 | GRK1 | 1.61245442 |
| 25 | PINK1 | 1.60234204 |
| 26 | ZAK | 1.52618934 |
| 27 | TRIB3 | 1.45044760 |
| 28 | MAP2K4 | 1.39796234 |
| 29 | MAPK11 | 1.35444023 |
| 30 | MAP3K7 | 1.35365877 |
| 31 | TAOK3 | 1.33017879 |
| 32 | TXK | 1.31078434 |
| 33 | SGK223 | 1.29017827 |
| 34 | SGK494 | 1.29017827 |
| 35 | PDK2 | 1.25876192 |
| 36 | TLK1 | 1.23558772 |
| 37 | PTK6 | 1.23041979 |
| 38 | LATS1 | 1.18679147 |
| 39 | DYRK2 | 1.15102412 |
| 40 | TIE1 | 1.14326283 |
| 41 | LIMK1 | 1.12157835 |
| 42 | MAPKAPK3 | 1.09439468 |
| 43 | PIK3CG | 1.06579438 |
| 44 | PRKAA2 | 1.04989939 |
| 45 | NLK | 1.04214068 |
| 46 | ABL2 | 1.03870417 |
| 47 | NTRK3 | 1.03622425 |
| 48 | RPS6KA5 | 1.03253341 |
| 49 | MAP3K3 | 1.03036752 |
| 50 | SGK3 | 1.02291720 |
| 51 | FLT3 | 1.02263670 |
| 52 | STK38 | 1.01525396 |
| 53 | EPHB1 | 0.94909626 |
| 54 | MAPK13 | 0.94869111 |
| 55 | CASK | 0.94013509 |
| 56 | SGK2 | 0.93530713 |
| 57 | FRK | 0.91845635 |
| 58 | ADRBK1 | 0.89989056 |
| 59 | TYK2 | 0.89901756 |
| 60 | GRK6 | 0.89298245 |
| 61 | NEK9 | 0.87841797 |
| 62 | PRKAA1 | 0.86204920 |
| 63 | MYLK | 0.86030746 |
| 64 | NUAK1 | 0.85703609 |
| 65 | GSK3A | 0.84139933 |
| 66 | MAP2K3 | 0.81564710 |
| 67 | DAPK2 | 0.79138920 |
| 68 | OBSCN | 0.78036615 |
| 69 | MELK | 0.77194753 |
| 70 | PRKCE | 0.77077916 |
| 71 | JAK2 | 0.77047058 |
| 72 | KDR | 0.76890940 |
| 73 | NME1 | 0.76569527 |
| 74 | WNK1 | 0.76005299 |
| 75 | BRSK2 | 0.75457187 |
| 76 | CAMKK2 | 0.72262145 |
| 77 | FGFR2 | 0.71869204 |
| 78 | MAPKAPK5 | 0.70664817 |
| 79 | DYRK1B | 0.69380480 |
| 80 | MAPK15 | 0.69287092 |
| 81 | NEK2 | 0.68725346 |
| 82 | MET | 0.68202789 |
| 83 | TGFBR2 | 0.65756115 |
| 84 | RIPK1 | 0.65673076 |
| 85 | PRKCZ | 0.65172968 |
| 86 | PTK2 | 0.64567220 |
| 87 | MAPK12 | 0.63658550 |
| 88 | FGFR3 | 0.62155223 |
| 89 | PRKACG | 0.59236217 |
| 90 | PAK3 | 0.58953644 |
| 91 | MAP3K14 | 0.58652476 |
| 92 | MUSK | 0.58007842 |
| 93 | CSNK1A1 | 0.57220971 |
| 94 | TTN | 0.57007483 |
| 95 | ERBB2 | 0.56147045 |
| 96 | PDPK1 | 0.55765236 |
| 97 | MAP3K11 | 0.53612198 |
| 98 | MAPK4 | 0.52368118 |
| 99 | MAP3K4 | 0.51047866 |
| 100 | PKN1 | 0.50992495 |
| 101 | CSNK1D | 0.50075870 |
| 102 | JAK1 | 0.49221101 |
| 103 | CAMK1D | 0.47936899 |
| 104 | DDR2 | 0.47161336 |
| 105 | CAMK2A | 0.46136380 |
| 106 | PNCK | 0.46008115 |
| 107 | CAMK2G | 0.42757947 |
| 108 | CAMK4 | 0.41201348 |
| 109 | LRRK2 | 0.41119936 |
| 110 | PRKG1 | 0.39876445 |
| 111 | TBK1 | 0.39767214 |
| 112 | MAPK3 | 0.39505555 |
| 113 | MAP3K10 | 0.38892519 |
| 114 | MAP2K6 | 0.37680023 |
| 115 | RPS6KA3 | 0.36110111 |
| 116 | MARK1 | 0.34958133 |
| 117 | PDK1 | 0.34882739 |
| 118 | TNIK | 0.34384293 |
| 119 | CSK | 0.33851788 |
| 120 | CDK6 | 0.32522450 |
| 121 | ICK | 0.31406247 |
| 122 | FER | 0.30939632 |
| 123 | MAP3K5 | 0.30632712 |
| 124 | EIF2AK3 | 0.30373385 |
| 125 | PIK3CA | 0.29973970 |
| 126 | SGK1 | 0.29410824 |
| 127 | MAPK1 | 0.29120846 |
| 128 | PRKCQ | 0.28558745 |
| 129 | PHKG2 | 0.28509481 |
| 130 | PHKG1 | 0.28509481 |
| 131 | IRAK3 | 0.27517600 |
| 132 | CAMK1G | 0.26795956 |
| 133 | MAPK7 | 0.25519044 |
| 134 | MTOR | 0.24800134 |
| 135 | MAP2K1 | 0.22619173 |
| 136 | IGF1R | 0.22502276 |
| 137 | AKT2 | 0.21865412 |
| 138 | PRKCA | 0.21804708 |
| 139 | PRKD1 | 0.21646574 |
| 140 | CSNK1G1 | 0.21372363 |
| 141 | PRKACA | 0.20804995 |
| 142 | LMTK2 | 0.20704582 |
| 143 | PRKACB | 0.17678337 |
| 144 | PRKCG | 0.15523838 |
| 145 | MAP3K2 | 0.15495360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.58388584 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.57579286 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.17448910 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.93181686 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.86442549 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.82459413 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.79898247 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.70734101 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67648277 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.64108060 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.62416964 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.54807530 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.50996977 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.41748011 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.28931540 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.25315443 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.19278256 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97915331 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95343767 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.89219063 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.88535602 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.83700440 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.80934019 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79985879 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.69276526 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69022897 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67668724 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.67367159 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.60965374 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.59276487 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56822941 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55381747 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52563581 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49490416 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.46484515 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45274551 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.44858811 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44121458 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43875358 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42790109 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28762944 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24622878 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.24476074 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23054214 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.22407018 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.17674433 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17639436 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13779678 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.13437034 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.07993303 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07249707 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 1.04544078 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.00513368 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99210284 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94408306 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89212123 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87060693 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.85490581 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83471419 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76449075 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75695194 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72489963 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59416681 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58062386 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58037249 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.56065966 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53044411 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51749454 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51582822 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51555240 |
| 71 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.51542899 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46718591 |
| 73 | Phototransduction_Homo sapiens_hsa04744 | 0.42604135 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.38342532 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37917998 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36287180 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30421765 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29596440 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29054118 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.26556247 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.25827328 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23206970 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.20366797 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.20176245 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20148829 |
| 86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.19548760 |
| 87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15889795 |
| 88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.15273057 |
| 89 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.15129143 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.14468990 |
| 91 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.12410716 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11512295 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.08751593 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.07677001 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.07253003 |
| 96 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.07180355 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05088687 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.03777522 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.03317877 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03049643 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.02540632 |
| 102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.01971235 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.01547587 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.01444894 |
| 105 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.1681221 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1653708 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1637200 |
| 108 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1390168 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1303958 |
| 110 | Lysosome_Homo sapiens_hsa04142 | -0.1125169 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1088238 |
| 112 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0695248 |
| 113 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0367845 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0304708 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0276939 |
| 116 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0134101 |

